FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1144477009: Relugolix (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4542089017 Relugolix (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4542090014 Relugolix en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4542089017 Relugolix (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4542090014 Relugolix en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Relugolix Has disposition Gonadotropin releasing hormone receptor antagonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Relugolix Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Relugolix Is a Gonadotropin releasing hormone receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Relugolix Is a Substance with benzene structure true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Relugolix-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relugolix Inferred relationship Existential restriction modifier (core metadata concept) 1
Relugolix only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relugolix Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing relugolix in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relugolix Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only relugolix in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relugolix Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely relugolix 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Relugolix Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely relugolix 120 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Relugolix Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start